4//SEC Filing
Baldry Mark 4
Accession 0001628280-22-028462
CIK 0001501697other
Filed
Nov 3, 8:00 PM ET
Accepted
Nov 4, 4:18 PM ET
Size
5.6 KB
Accession
0001628280-22-028462
Insider Transaction Report
Form 4
Baldry Mark
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2022-11-03$1.89/sh+341,000$644,490→ 341,000 totalExercise: $1.89Exp: 2032-11-03→ Common Stock (341,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on November 3, 2023, with the remainder vesting in equal installments of 2.0833% of the shares subject to the option each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001644137
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 8:00 PM ET
- Accepted
- Nov 4, 4:18 PM ET
- Size
- 5.6 KB